MFH of Bone and Osteosarcoma Show Similar Survival and Chemosensitivity

Authors:
  • WSWon Seok Song
    Won Seok Song
  • CKChang-Bae Kong
    Chang-Bae Kong
  • JKJung Ryul Kim
    Jung Ryul Kim
  • SLSoo-Yong Lee
    Soo-Yong Lee

Abstract
A difference in the initial tumor volume, histologic response, and survival between cohorts with MFH-B and osteosarcoma, and (2) whether histologic responses and survival rates differed between two groups even after matching for volume and age. Patients and Methods We retrospectively compared 27 patients with Stage IIB MFH-B with 389 patients with localized osteosarcoma for initial tumor volume, age, histologic response, and survival. We compared histologic response and survival between 27 patients with MFH-B and 54 patients with osteosarcoma matched for tumor volume and age. Results MFH-B occurred more frequently in older patients and they presented with a smaller mean tumor volume and more frequent osteolytic pattern when compared with patients with osteosarcoma. The 5-year metastasis-free survival rates of the MFH-B and osteosarcoma groups were similar: 61.2% ± 9.7% and 61.3% ± 2.5%, respectively. We observed similar proportions of good responders to chemotherapy in the two groups, and the 5-year metastasis-free survival rates were 61.2% ± 9.7% and 70.4% ± 6.2%, respectively. Conclusions Patients with MFH-B and osteosarcoma have similar survival rates and histologic responses to chemotherapy. Although MFH-B and osteosarcoma differ in clinical presentation, their response pattern to contemporary therapy is similar. Level of Evidence Level III, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence....

This publication has 26 references indexed in Scilit: